Material Agreements

Evofem Biosciences, Inc. amended Merger Agreement with Aditxt, Inc. valued at Reinstated and amended Merger Agreement via Fourth Amendment, including $1,000,000 initial payment, (effective 2024-05-02).

“On May 2, 2024, the Company, the Merger Sub and Aditxt entered into the Reinstatement and Fourth Amendment to the Merger Agreement (the "Fourth Amendment") in order to waive and amend, among other things, the several provisions listed below.”

Evofem Biosciences, Inc. terminated Merger Agreement with Aditxt, Inc. valued at Company terminated Merger Agreement effective April 26, 2024 in accordance with Section 8.1(f) of th (effective 2024-04-26).

“On April 26, 2024, the Company delivered a termination notice to Aditxt notifying it that the Company was exercising its right to terminate the Merger Agreement effective April 26, 2024 (the "Termination Notice"), in accordance with Section 8.1(f) of the Merger Agreement, as revised in the third amendment to the Merger Agreement, made on February 29, 2024.”

TriplePoint Venture Growth BDC Corp. terminated Prior Sales Agreement with UBS Securities LLC valued at termination of the Prior Sales Agreement (effective 2024-05-02).

“Concurrently upon entry into the Sales Agreement, t he Company, the Adviser, the Administrator and the Sales Agent, which were each a party to that certain Sales Agreement, dated September 30, 2022 (the “Prior Sales Agreement”), agreed to the termination of the Prior Sales Agreement.”

TriplePoint Venture Growth BDC Corp. entered into Sales Agreement with UBS Securities LLC valued at up to $75 million in aggregate amount of the Company’s common stock (effective 2024-05-02).

“On May 2, 2024, TriplePoint Venture Growth BDC Corp. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with TriplePoint Advisers LLC (the “Adviser”), TriplePoint Administrator LLC (the “Administrator”) and UBS Securities LLC (the “Sales Agent”), providing for the issuance and sale of up to $75 million in aggregate amount of the Company’s common stock, par value $0.01 per share (the “Shares”).”

United Parks & Resorts Inc. amended Amendment with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent valued at $380 million (effective 2024-05-02).

“On May 2, 2024, United Parks & Resorts Inc. (the “Company”) entered into a fungible incremental term loan facility (the “Amendment”) under that certain Amended and Restated Credit Agreement, dated as of August 25, 2021 (and as amended on June 9, 2022, June 12, 2023 and January 22, 2024), among the Company, SeaWorld Parks & Entertainment, Inc., the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Credit Agreement”).”

Thryv Holdings, Inc. entered into ABL Credit Agreement with Citizens Bank, N.A. valued at $85.0 million (effective 2024-05-01).

“On May 1, 2024, the Company entered into a new Credit Agreement (the “ABL Credit Agreement”) among the Company, the Borrower, the other borrowers from time to time party thereto, the lenders from time to time party thereto, and Citizens Bank, N.A., as administrative agent”

Thryv Holdings, Inc. entered into Term Loan Agreement with Citizens Bank, N.A. valued at $350.0 million (effective 2024-05-01).

“On May 1, 2024, Thryv Holdings, Inc. (the “Company”) entered into a new Term Loan Credit Agreement (the “Term Loan Agreement”), by and among the Company, Thryv, Inc., a direct and wholly-owned subsidiary of the Company (the “Borrower”), the lenders party thereto from time to time, and Citizens Bank, N.A., as the administrative agent”

Shutterstock, Inc. entered into Share Purchase Agreement with Garnett-Saunders Pty Ltd, Draconis Holdings Pty Ltd and Ta’eed Felah Pty Ltd valued at approximately $245 million (effective 2024-05-01).

“On May 1, 2024, Shutterstock, Inc. (the “Company”) entered into a Share Purchase Agreement (the “Purchase Agreement”) with Garnett-Saunders Pty Ltd, Draconis Holdings Pty Ltd and Ta’eed Felah Pty Ltd (collectively, the “Sellers”) and Shutterstock AUS EMU Pty Ltd., a wholly owned indirect subsidiary of the Company (“Purchaser”), pursuant to which the Sellers have agreed to sell, and Purchaser has agreed to purchase (the “Acquisition”), all of the issued and outstanding capital stock of Envato Pty Ltd. (“Envato”).”

CIMG Inc. entered into Purchase Agreement with certain investors valued at $320,000 (effective 2024-04-27).

“On April 27, 2024, NuZee, Inc., a Nevada corporation (the “Company”), entered into a convertible note and warrant purchase agreement (the “Purchase Agreement”) with certain investors (the “Investors”), providing for the private placement of convertible promissory notes in the aggregate principal amount of $320,000 (the “Notes”) and warrants (the “Warrants”) to purchase up to an aggregate of 221,147 shares of the Company’s common stock”

PERPETUA RESOURCES CORP. amended Technology Investment Agreement with United States Department of Defense, Air Force Research Laboratory valued at $59,224,176 (effective 2024-05-02).

“On May 2, 2024, the Company received approval of the previously announced modification to the DPA TIA for an award of $34,412,114 in additional funding under the TIA and entered into an amendment to the TIA increasing the total amount of the TIA to $59,224,176.”

Invitae Corp entered into Asset Purchase Agreement with Laboratory Corporation of America Holdings (Labcorp) and Labcorp Genetics Inc. (the Purchaser) valued at $239,000,000 (effective 2024-05-01).

“On May 1, 2024, the Company entered into an asset purchase agreement (the "Asset Purchase Agreement") with Laboratory Corporation of America Holdings ("Labcorp"), solely in its capacity as guarantor, and with Labcorp Genetics Inc. (the "Purchaser"), an affiliate of Labcorp, as purchaser, as a result of the Purchaser being selected as the successful bidder in an auction authorized by the Court pursuant to, inter alia, sections 105, 363, and 365 of the United States Bankruptcy Code.”

Scorpius Holdings, Inc. amended Restated Note with Elusys Holdings Inc. valued at $2,250,000 (effective 2024-05-01).

“agreed to issue to Buyer an amended and restated 1% convertible promissory note in the principal amount of $2,250,000 (the “Restated Note”) in exchange for that certain prior 1% convertible promissory note, dated January 26, 2024, issued to Buyer in the principal amount of $2,250,000 to amend Section 2(b) thereof relating to certain adjustments in the conversion price and extend its maturity date to September 1, 2025”

Scorpius Holdings, Inc. entered into Note Purchase Agreement with Elusys Holdings Inc. valued at $750,000 (effective 2024-05-01).

“On May 1, 2024, Scorpius Holdings, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Purchase Agreement”) with Elusys Holdings Inc., a Delaware corporation (“Buyer”), which is a company controlled by the Company’s Chairman, Chief Executive Officer and President, Jeffrey Wolf, pursuant to which the Buyer agreed to loan the Company $750,000 and the Company agreed to sell to the Buyer a 1% non-convertible promissory note due July 1, 2024 in the principal amount of $750,000 (the “Note”) for $750,000 in cash”

Cinemark Holdings, Inc. terminated 8.750% Senior Secured Notes due 2025 with Computershare Trust Company, N.A. valued at $150,000,000 in aggregate principal amount (effective 2024-04-01).

“On April 1, 2024, Computershare Trust Company, N.A. (successor to Wells Fargo Bank, N.A.), as trustee (the “Trustee”) and collateral agent for the 8.750% Notes (as defined below), sent a notice of optional full redemption on behalf of Cinemark USA, Inc. (“Cinemark USA”) to the holders of the 8.750% Notes, electing to redeem (the “Redemption”) $150,000,000 in aggregate principal amount of Cinemark USA’s outstanding 8.750% Senior Secured Notes due 2025”

Cardinal Ethanol LLC amended Ethanol Purchase and Sale Agreement with Murex LLC valued at Amendment No. 5 to the Ethanol Purchase and Sale Agreement, extends term, requires Murex to provide (effective 2024-04-26).

“Cardinal Ethanol, LLC ("Cardinal Ethanol") entered into Amendment No. 5 to the Ethanol Purchase and Sale Agreement with Murex LLC ("Murex") for the purpose of marketing and distributing all of the ethanol we produce at our plant in Union City, Indiana.”

EnerSys entered into Stock Purchase Agreement with the Sellers (as defined in the Agreement) valued at approximately $208 million (effective 2024-05-02).

“On May 2, 2024, EnerSys Advanced Systems Inc., a Delaware corporation (the “ Buyer ”) and a wholly-owned subsidiary of EnerSys, a Delaware corporation (the “ Company ”), entered into a Stock Purchase Agreement (the “ Agreement ”) with Michael Brenna 2015 Irrevocable Trust Dated 08/17/15, the Trust U/A Third (E) of the Leo. A. Brenna Revocable Trust Dated 02/07/2014 GST Exempt Trust F/B/O Michael Brenna, and the Trust U/A Third (E) of the Leo. A. Brenna Revocable Trust Dated 02/07/2014 Non GST Exempt Trust F/B/O Michael Brenna (each, a “ Seller ” and collectively, “ Sellers ”) and Barbara Dworkin, as Sellers’ representative. Pursuant to the terms of the Agreement, the Buyer will acquire 100% of the equity interests of Bren-Tronics, Inc., a New York corporation and a leader in the design, manufacturing, and marketing of advanced portable power solutions (the “ Acquired Company ”) from the Sellers, including both plots of real estate held by a related party (such stock and asset acquisiti”

WFN CREDIT CO LLC amended First Addendum to Appendix A with Comenity Servicing LLC (effective 2024-04-30).

“On April 30, 2024, Comenity Bank (“Bank”) and Comenity Servicing LLC (“Servicer”) entered into the First Addendum to Appendix A (“First Addendum”) to that certain Fifth Amended and Restated Service Agreement, dated as of April 1, 2024 (the “Service Agreement”), by and between Bank and Servicer”

Bio Green Med Solution, Inc. entered into Purchase Agreement with an institutional investor valued at approximately $8.0 million (effective 2024-04-30).

“On April 30, 2024, Cyclacel Pharmaceuticals, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with an institutional investor (the “ Purchaser ”) for the issuance and sale in a private placement (the “ Private Placement ”) of (i) 145,000 shares of the Company’s common stock”

NORTHWEST BIOTHERAPEUTICS INC entered into Loan Agreement with Streeterville Capital, LLC valued at $11,005,000 (effective 2024-04-26).

“On April 26, 2024, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Commercial Loan Agreement and Note (collectively, the “Loan Agreement”) with Streeterville Capital, LLC (the “Holder”) in the amount of $11,005,000.”

WD 40 CO entered into Fourth Amendment to Note Purchase and Private Shelf Agreement with PGIM, Inc. valued at Amendment to permit entry into 2nd A&R Credit Agreement with Bank of America and include conforming (effective 2024-04-30).

“On April 30, 2024, the Company entered into a fourth amendment (the “4 th Amendment”) to the Note Purchase and Private Shelf Agreement dated November 15, 2017 (as amended on February 23, 2018, March 16, 2020, and September 30, 2020, collectively, the “Note Agreement”) by and among the Company and PGIM, Inc. (“Prudential”), and certain affiliates and managed accounts of Prudential (collectively with Prudential, the “Note Purchasers”).”

WD 40 CO entered into Second Amended and Restated Credit Agreement with Bank of America, N.A. valued at Revolving Commitment decreased from $150 million to $125 million; sublimit decreased from $100 milli (effective 2024-04-30).

“On April 30, 2024, WD-40 Company (the “Company”), and certain subsidiaries of the Company, entered into a Second Amended and Restated Credit Agreement (the “2 nd A&R Credit Agreement”) with Bank of America, N.A. (“Bank of America”).”

GROUP 1 AUTOMOTIVE INC amended Increase Documents with certain subsidiaries valued at $500.0 million (effective 2024-04-30).

“Group 1 Automotive, Inc. (the “Company”) and certain subsidiaries of the Company entered into an amendment (together with certain commitment increase agreements entered into in connection therewith, collectively, the “Increase Documents”) to the Company’s existing twelfth amended and restated revolving credit agreement (the “Credit Agreement” and the revolving credit facility established thereby, the “Credit Facility”), which Increase Documents increased the total commitments under the Credit Facility by $500.0 million”

SOCKET MOBILE, INC. amended Secured Subordinated Convertible Note Extension Agreement with requisite holders of the outstanding notes valued at Extension Agreement extending maturity date from August 30, 2024 to August 30, 2025 (effective 2024-05-01).

“On May 1, 2024, the Company and the requisite holders of the outstanding notes entered into a Secured Subordinated Convertible Note Extension Agreement (the “Extension Agreement”), extending the maturity date of the notes from August 30, 2024, to August 30, 2025.”

DAVITA INC. entered into Share Repurchase Agreement with Berkshire Hathaway Inc. valued at share repurchase agreement: Company to repurchase from Investor shares sufficient to return benefici (effective 2024-04-30).

“On April 30, 2024, DaVita Inc. (the “Company”) entered into a letter agreement (the “Share Repurchase Agreement”) with Berkshire Hathaway Inc., on behalf of itself and its Affiliates (as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended) (collectively, “Investor”), the largest stockholder of the Company.”

COOPER COMPANIES, INC. terminated 2020 Credit Agreement with KeyBank, National Association, as administrative agent (effective 2024-05-01).

“On May 1, 2024, in connection with the Company’s entry into the Credit Agreement, the Company terminated its existing Revolving Credit and Term Loan Agreement, dated as of April 1, 2020 (as subsequently amended, the “2020 Credit Agreement”), among the Company, CooperVision International, the lenders from time to time party thereto, KeyBank, National Association, as administrative agent, and the other parties thereto.”

COOPER COMPANIES, INC. amended Amendment No. 2 to Term Loan Agreement with PNC Bank, National Association, as administrative agent (effective 2024-05-01).

“On May 1, 2024, the Company entered into Amendment No. 2 to Term Loan Agreement (the “Second Amendment to 2021 Loan Agreement”), among the Company, the lenders party thereto, and PNC Bank, as administrative agent, to amend the Term Loan Agreement, dated as of December 17, 2021 (as previously amended, the “2021 Loan Agreement”), by and among the Company, the lenders from time to time party thereto, PNC Bank, as administrative agent, and the other parties thereto.”

COOPER COMPANIES, INC. entered into Revolving Credit Agreement with PNC Bank, National Association, as administrative agent valued at $2.300 billion (effective 2024-05-01).

“On May 1, 2024, The Cooper Companies, Inc. (the “Company”) entered into a Revolving Credit Agreement (the “Credit Agreement”), among the Company, CooperVision International Limited (“CooperVision International” and, together with the Company, individually each a “Borrower” and collectively, the “Borrowers”), the lenders from time to time party thereto, PNC Bank, National Association (“PNC Bank”), as administrative agent, and the other parties thereto.”

HAEMONETICS CORP amended Revised Credit Agreement with JPMorgan Chase Bank, N.A. valued at $250 million senior unsecured term loan (effective 2024-04-30).

“On April 30, 2024, Haemonetics Corporation (the “Company”) entered into a second amended and restated credit agreement by and among the Company, as borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Revised Credit Agreement”).”

RenX Enterprises Corp. terminated Contribution Agreement with Preserve Acquisitions, LLC (effective 2024-04-25).

“Prior to entering into the Contract of Sale, the Company notified Preserve of its intention to enter into the Contract of Sale. As a result, on April 25, 2024, the Company received written notice from counsel to Preserve terminating the Contribution Agreement.”

RenX Enterprises Corp. entered into Contract of Sale with Lithe Development Inc. valued at $5.825 million (effective 2024-04-25).

“On April 25, 2024, the Company entered into a Commercial Contract (the “Contract of Sale”) with Lithe Development Inc., a Texas corporation (“Lithe”), to sell the Company’s approximately 60-acre waterfront Lago Vista site in Lake Travis, Texas (the “Lago Vista Site”) owned by the Company to Lithe for $5.825 million.”

RenX Enterprises Corp. amended Amendment with Pigmental, LLC (effective 2024-04-25).

“As of April 25, 2024, Safe and Green Development Corporation (the “Company”) entered into an amendment to the agreement of sale (the “Amendment”) with Pigmental, LLC, a Delaware limited liability company (“Pigmental Studios”), to sell approximately 27 acres of land zoned for a manufacturing facility in St. Mary’s, Georgia (the “St. Mary’s Industrial Site”).”

Alternus Clean Energy, Inc. entered into Membership Interest Purchase and Sale Agreement with C2 Taiyo Fund I, LP valued at approximately $15 million (effective 2024-04-30).

“On April 30, 2024, ALT US 01 LLC (“ ALT ”), a company incorporated under the laws of Delaware and indirect wholly owned subsidiary of Alternus Clean Energy, Inc. (the “ Company ”) entered into a Membership Interest Purchase and Sale Agreement (the “ MIPA ”) by and among ALT and C2 Taiyo Fund I, LP, a Delaware limited partnership (“ C2 ”).”

Learn CW Investment Corp entered into Amendment No. 1 to Investment Management Agreement with U.S. Bank, National Association valued at Investment Management Agreement amended to allow investment of trust account funds in interest-beari (effective 2024-04-25).

“On April 25, 2024, Learn CW Investment Corporation (the “Company”) entered into Amendment No. 1 (“Amendment No. 1”) to the Investment Management Agreement, dated October 12, 2021 (the “Trust Agreement”), by and between the Company and U.S. Bank, National Association, as trustee.”

Getaround, Inc amended Fourth A&R Note with Mudrick Capital Management L.P. valued at $61,677,504.04 (effective 2024-04-29).

“On April 29, 2024, Getaround, Inc. (the “Company”) and Mudrick Capital Management L.P., on behalf of certain funds, investors, entities or accounts that are managed, sponsored or advised by Mudrick Capital Management L.P. (the “Purchaser”), amended and restated the amended and restated super priority secured promissory note entered into by such parties on February 7, 2024 (the "Fourth A&R Note"), which replaced the Third A&R Note described in our current report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on January 24, 2024, to reflect an increased aggregate principal amount of $61,677,504.04”

JOANN Inc. entered into Second Amended and Restated Credit Agreement (Exit ABL Credit Agreement) with Company Parties valued at amends and restates Existing ABL/FILO Facilities, extends maturity to June 22, 2027 (effective 2024-05-01).

“On the Effective Date, in connection with the Exit Term Loan Credit Agreement, and pursuant to the terms of the Plan, the Company Parties also entered into a Second Amended and Restated Credit Agreement (the “Exit ABL Credit Agreement”), which amended and restated the Company’s existing Amended and Restated Credit Agreement, dated as of October 21, 2016, relating to the Company’s existing senior secured asset-based revolving credit facility and existing senior secured asset-based first-in last-out credit facility (the “Existing ABL/FILO Facilities” and as amended and restated by the Exit ABL Credit Agreement, the “Exit ABL/FILO Facilities”).”

JOANN Inc. entered into Exit Term Loan Credit Agreement with DIP Lenders valued at approximately $153.7 million aggregate principal amount (effective 2024-05-01).

“New Exit Term Loan Credit Agreement On the Effective Date, the Company Parties entered into an exit term loan credit agreement (the “Exit Term Loan Credit Agreement”) with the lenders under the DIP Facility (the “DIP Lenders”), providing for approximately $153.7 million aggregate principal amount of exit term loans comprised of converted DIP Term Loans in the same aggregate principal amount (plus accrued interest and fees payable in kind, if any) based on amounts outstanding under the DIP Facility on the Effective Date (the “Exit Term Loans”).”

Motorsport Games Inc. entered into Asset Purchase Agreement with Traxion.GG Limited valued at $250,000 (effective 2024-04-26).

“On April 26, 2024, Motorsport Games Inc., a Delaware corporation (the “Company”), entered into an Asset Purchase Agreement (the “Agreement”) with Traxion.GG Limited (“Traxion.GG”).”

Astra Space, Inc. amended Fourth Amendment to Senior Secured Convertible Notes with the holders of the approximately $31.71 million outstanding aggregate principal amount of the Note Parties’ 12.0% Senior Secured Convertible Notes due 2025 valued at approximately $31.71 million outstanding aggregate principal amount (effective 2024-04-30).

“On April 30, 2024, Astra Space, Inc. (the “ Company ”) and its subsidiaries (collectively with the Company, the “ Note Parties ”) entered into a Fourth Amendment to Senior Secured Convertible Notes (the “ Amendment ”) with each of the holders (the “ Holders ”) of the approximately $31.71 million outstanding aggregate principal amount of the Note Parties’ 12.0% Senior Secured Convertible Notes due 2025 (the “ Convertible Notes ”)”

Innovative Eyewear Inc entered into Securities Purchase Agreement with institutional investors valued at $1,000,000 gross proceeds (effective 2024-04-28).

“On April 28, 2024, Innovative Eyewear, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain institutional investors (the “ Investors ”) for the purpose of raising approximately $1 million in gross proceeds for the Company.”

DoorDash, Inc. amended Amendment Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at $800.0 million (effective 2024-04-26).

“On April 26, 2024 (the “ Effective Date ”), DoorDash, Inc., a Delaware corporation (the “ Company ”), entered into an Amendment Agreement (the “ Amendment Agreement ”) pursuant to which its existing Revolving Credit and Guaranty Agreement”

Metagenomi Therapeutics, Inc. terminated Strategic Collaboration and License Agreement with ModernaTX, Inc. (effective 2024-04-26).

“On April 26, 2024 (the “Termination Date”), Metagenomi, Inc. (the “Company”) and ModernaTX, Inc. (“Moderna”) mutually terminated the Strategic Collaboration and License Agreement dated October 29, 2021 (the “Collaboration Agreement”) by and between the Company and Moderna.”

Tilray Brands, Inc. entered into Assignment and Assumption Agreement with Double Diamond Holdings Ltd. valued at USD$10,883,496 (effective 2024-04-30).

“On April 30, 2024, Tilray Brands, Inc., a Delaware corporation (“Tilray”), entered into an assignment and assumption agreement (the “Assignment and Assumption Agreement”) with Double Diamond Holdings Ltd. (“DDH”), an Ontario corporation, pursuant to which, among other things, Tilray acquired from DDH a promissory note in the amount of USD$10,883,496 (the “Note”) payable by 1974568 Ontario Limited (“Aphria Diamond”).”

IMAC Holdings, Inc. entered into Settlement and Release Agreement with Theralink Technologies, Inc. (effective 2024-05-01).

“On May 1, 2024, the Company entered into a Settlement and Release Agreement with Theralink (the “Settlement Agreement”) pursuant to which the parties agreed to a settlement of the default by Theralink under the previously announced Credit Agreement dated April 11, 2024 between the Company as Lender and Theralink as Borrower (the “Theralink Credit Agreement”).”

IMAC Holdings, Inc. entered into Securities Purchase Agreement with various holders (the "Note Holders") of senior secured convertible debentures of Theralink Technologies, Inc. valued at aggregate principal amount outstanding of $16,221,873.89 (effective 2024-04-30).

“On April 30, 2024, IMAC Holdings, Inc. (the “Company”) entered into securities purchase agreements (each, a “Securities Purchase Agreement”) with various holders (the “Note Holders”) of senior secured convertible debentures (the “Notes”) of Theralink Technologies, Inc. (“Theralink”) for the sale of shares of the Company’s newly created Series D Convertible Preferred Stock, $0.001 par value (the “Series D Preferred Stock”).”

PROCACCIANTI HOTEL REIT, INC. entered into Loan Agreement with Liberty Bank valued at aggregate amount of $23,670,000 (effective 2024-04-26).

“(i) PHR STPFL, LLC, a Delaware limited company and wholly-owned subsidiary of the Fund (“PHR STPFL”), as borrower, and Liberty Bank, as the lender, entered into the Loan Agreement dated as of April 25, 2024 (the “St. Petersburg Hotel Loan"), and (ii) PHR WNC, LLC, a Delaware limited company and wholly-owned subsidiary of the Fund (“PHR WNC”), as borrower, and Liberty Bank, as the lender, entered into the Loan Agreement dated April 26, 2024 (the “Wilmington Hotel Loan", and together with the St. Petersburg Hotel Loan, the “Refinancing Loans”).”

International Seaways, Inc. amended $500 Million RCF with Nordea Bank Abp, New York Branch valued at $500 million revolving credit facility, maturing January 31, 2030 (effective 2024-04-26).

“On April 26, 2024, International Seaways, Inc. (the “ Company ”), International Seaways Operating Corporation (the “ Borrower ”) and certain of their subsidiaries entered into a second amendment that amended and extended that certain credit agreement dated as of May 22, 2022, as amended from time to time (the “ $750 Million Credit Facility ”) with Nordea Bank Abp, New York Branch (“ Nordea ”), BNP Paribas, Crédit Agricole Corporate & Investment Bank (“ CA-CIB ”), DNB Markets Inc., and Skandinaviska Enskilda Banken AB (PUBL) (or their respective affiliates), as mandated lead arrangers and bookrunners; and ING Bank N.V., London Branch and Danish Ship Finance A/S and (or their respective affiliates), as lead arrangers and National Australia Bank Limited as co-arranger.”

Poseida Therapeutics, Inc. entered into Collaboration Agreement with Xyphos Biosciences, Inc. valued at $50.0 million (effective 2024-04-30).

“On April 30, 2024, Poseida Therapeutics, Inc. (the “Company”) and Xyphos Biosciences, Inc., a wholly-owned subsidiary of Astellas Pharma Inc. (“Xyphos”), entered into a collaboration and license agreement (the “Collaboration Agreement”),”

Permian Resources Corp amended Seventh Amendment with JPMorgan Chase Bank, N.A., as administrative agent (effective 2024-04-25).

“On April 25, 2024, Permian Resources Operating, LLC (“ OpCo ”), a consolidated subsidiary of Permian Resources Corporation (the “ Company ”), entered into the Seventh Amendment to the Third Amended and Restated Credit Agreement (the “ Seventh Amendment ”), dated as of April 25, 2024, among OpCo, each of the lenders and guarantors party thereto and JPMorgan Chase Bank, N.A., as administrative agent”

AVENUE THERAPEUTICS, INC. entered into Inducement Letters with certain investors (the October 2022 Investors, November 2023 Investors, and January 2024 Investors) valued at approximately $4.4 million (effective 2024-04-28).

“On April 28, 2024, Avenue Therapeutics, Inc. (the “ Company ”) entered into inducement offer letter agreements (the “ Inducement Letters ”) with (i) certain investors (the “ October 2022 Investors ”) that hold certain outstanding warrants to purchase up to an aggregate of 27,271 shares of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), originally issued to the October 2022 Investors on October 11, 2022 (the “ October 2022 Warrants ”); (ii) certain investors (the “ November 2023 Investors ”) that hold certain outstanding Series A and Series B warrants to purchase up to an aggregate of 221,333 shares of Common Stock, originally issued to the November 2023 Investors on October 31, 2023 (the “ November 2023 Warrants ”); and (iii) certain investors (the “ January 2024 Investors ” and, collectively with the October 2022 Investors and November 2023 Investors, the “ Holders ”) that hold certain outstanding Series A and Series B warrants to purchase up to an agg”

Freshworks Inc. entered into Agreement and Plan of Merger with Device42 valued at $230 million (effective 2024-04-30).

“On April 30, 2024, Freshworks Inc. (“Freshworks” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with D42 Parent, Inc., a Delaware corporation (“Device42”), pursuant to which Freshworks”